Roffman Miller Associates Inc Johnson & Johnson Transaction History

Roffman Miller Associates Inc

  • $1.64 Billion
  • Q3 2024

A detailed history of Roffman Miller Associates Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Roffman Miller Associates Inc holds 259,281 shares of JNJ stock, worth $37.5 Million. This represents 2.57% of its overall portfolio holdings.

Number of Shares
259,281
Previous 250,252 3.61%
Holding current value
$37.5 Million
Previous $36.6 Million 14.88%
% of portfolio
2.57%
Previous 2.41%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024
BUY
$145.48 - $167.38 $1.31 Million - $1.51 Million
9,029 Added 3.61%
259,281 $42 Million
Q2 2024

Jul 30, 2024
BUY
$144.38 - $157.78 $987,414 - $1.08 Million
6,839 Added 2.81%
250,252 $36.6 Million
Q1 2024

May 07, 2024
BUY
$155.22 - $162.74 $375,011 - $393,179
2,416 Added 1.0%
243,413 $38.5 Million
Q4 2023

Feb 02, 2024
BUY
$145.6 - $158.88 $13,832 - $15,093
95 Added 0.04%
240,997 $37.8 Million
Q3 2023

Nov 09, 2023
BUY
$155.75 - $174.48 $561,634 - $629,174
3,606 Added 1.52%
240,902 $37.5 Million
Q2 2023

Aug 07, 2023
BUY
$154.35 - $166.11 $434,649 - $467,765
2,816 Added 1.2%
237,296 $39.3 Million
Q1 2023

May 10, 2023
BUY
$151.05 - $180.26 $80,056 - $95,537
530 Added 0.23%
234,480 $36.3 Million
Q4 2022

Jan 17, 2023
BUY
$160.2 - $179.79 $18,583 - $20,855
116 Added 0.05%
233,950 $0
Q3 2022

Nov 07, 2022
BUY
$161.33 - $179.52 $216,988 - $241,454
1,345 Added 0.58%
233,834 $38.2 Million
Q2 2022

Aug 08, 2022
SELL
$168.19 - $186.01 $580,423 - $641,920
-3,451 Reduced 1.46%
232,489 $41.3 Million
Q1 2022

May 24, 2022
SELL
$158.14 - $179.59 $158,298 - $179,769
-1,001 Reduced 0.42%
235,940 $41.8 Million
Q4 2021

Feb 03, 2022
BUY
$155.93 - $173.01 $574,134 - $637,022
3,682 Added 1.58%
236,941 $40.5 Million
Q3 2021

Nov 15, 2021
SELL
$161.5 - $179.47 $33.6 Million - $37.3 Million
-207,906 Reduced 47.13%
233,259 $37.7 Million
Q2 2021

Aug 06, 2021
BUY
$159.48 - $171.07 $772,999 - $829,176
4,847 Added 1.11%
441,165 $72.7 Million
Q1 2021

Apr 16, 2021
BUY
$153.07 - $170.48 $14.7 Million - $16.4 Million
96,018 Added 28.22%
436,318 $37.5 Million
Q4 2020

Feb 16, 2021
BUY
$137.11 - $157.38 $16.1 Million - $18.5 Million
117,754 Added 52.91%
340,300 $35 Million
Q3 2020

Nov 06, 2020
SELL
$140.38 - $153.83 $232,750 - $255,050
-1,658 Reduced 0.74%
222,546 $33.1 Million
Q2 2020

Nov 06, 2020
BUY
$128.81 - $155.51 $415,154 - $501,208
3,223 Added 1.46%
224,204 $31.5 Million
Q1 2020

May 14, 2020
BUY
$111.14 - $153.99 $944,912 - $1.31 Million
8,502 Added 4.0%
220,981 $29 Million
Q4 2019

Jan 24, 2020
SELL
$127.5 - $146.44 $170,977 - $196,376
-1,341 Reduced 0.63%
212,479 $31 Million
Q3 2019

Nov 04, 2019
SELL
$126.95 - $142.14 $335,148 - $375,249
-2,640 Reduced 1.22%
213,820 $27.7 Million
Q2 2019

Aug 09, 2019
SELL
$131.15 - $144.24 $218,889 - $240,736
-1,669 Reduced 0.77%
216,460 $30.1 Million
Q1 2019

May 15, 2019
BUY
$125.72 - $139.79 $1.03 Million - $1.14 Million
8,187 Added 3.9%
218,129 $30.5 Million
Q4 2018

Feb 11, 2019
SELL
$122.84 - $147.84 $340,389 - $409,664
-2,771 Reduced 1.3%
209,942 $27.1 Million
Q3 2018

Nov 06, 2018
BUY
$121.58 - $142.88 $302,369 - $355,342
2,487 Added 1.18%
212,713 $29.4 Million
Q2 2018

Aug 07, 2018
BUY
$119.4 - $131.76 $692,639 - $764,339
5,801 Added 2.84%
210,226 $25.5 Million
Q1 2018

May 01, 2018
BUY
$125.1 - $148.14 $725,580 - $859,211
5,800 Added 2.92%
204,425 $26.2 Million
Q4 2017

Feb 06, 2018
SELL
$131.22 - $143.62 $18,895 - $20,681
-144 Reduced 0.07%
198,625 $27.8 Million
Q3 2017

Nov 03, 2017
BUY
$129.47 - $135.38 $25.7 Million - $26.9 Million
198,769
198,769 $25.8 Million

Others Institutions Holding JNJ

# of Institutions
4,276
Shares Held
1.68B
Call Options Held
17.6M
Put Options Held
14.5M
View Full List

About JOHNSON & JOHNSON

JNJ Quotes by TradingView
  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $378B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Roffman Miller Associates Inc Portfolio

Follow Roffman Miller Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Roffman Miller Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Roffman Miller Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email